The Proteolytic Systems of Muscle Wasting

ISSN： 2352-0922

Source： Recent Advances in DNA & Gene Sequences (Formerly Recent Patents on DNA & Gene Sequences), Vol.9, Iss.1, 2015-04, pp. : 26-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for sarcopenia: age-related muscle wasting

By Lynch Gordon S

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 2, 2004-11 ,pp. : 345-361

Informa Healthcare

Access to resources Recommend Favorite

Update on emerging drugs for sarcopenia – age-related muscle wasting

By Lynch Gordon S

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. : 655-673

Informa Healthcare

Access to resources Recommend Favorite

Novel therapies for muscular dystrophy and other muscle wasting conditions

By Lynch G.S.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 4, 2001-04 ,pp. : 587-601

Informa Healthcare

Access to resources Recommend Favorite

Update on therapies for sarcopenia: novel approaches for age-related muscle wasting and weakness

By Lynch Gordon S

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 9, 2004-09 ,pp. : 1329-1344

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic effects of anabolic androgenic steroids on chronic diseases associated with muscle wasting

By Woerdeman Jorn de Ronde Willem

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 1, 2011-01 ,pp. : 87-97

Informa Healthcare

Access to resources Recommend Favorite